243 related articles for article (PubMed ID: 26894506)
1. Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival.
Glaser SM; Mandish SF; Gill BS; Balasubramani GK; Clump DA; Beriwal S
Head Neck; 2016 Apr; 38 Suppl 1():E2083-90. PubMed ID: 26894506
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
Pezzi TA; Mohamed ASR; Sheu T; Blanchard P; Sandulache VC; Lai SY; Cabanillas ME; Williams MD; Pezzi CM; Lu C; Garden AS; Morrison WH; Rosenthal DI; Fuller CD; Gunn GB
Cancer; 2017 May; 123(9):1653-1661. PubMed ID: 28026871
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy Plus Chemotherapy Leads to Prolonged Survival in Patients With Anaplastic Thyroid Cancer Compared With Radiotherapy Alone Regardless of Surgical Resection and Distant Metastasis: A Retrospective Population Study.
Zhou W; Yue Y; Zhang X
Front Endocrinol (Lausanne); 2021; 12():748023. PubMed ID: 34790169
[TBL] [Abstract][Full Text] [Related]
4. Survival and prognostic factors of anaplastic thyroid carcinoma.
Paunovic IR; Sipetic SB; Zoric GV; Diklic AD; Savic DV; Marinkovic J; Zivaljevic VR
Acta Chir Belg; 2015; 115():62-7. PubMed ID: 26021793
[TBL] [Abstract][Full Text] [Related]
5. Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012.
Baek SK; Lee MC; Hah JH; Ahn SH; Son YI; Rho YS; Chung PS; Lee YS; Koo BS; Jung KY; Lee BJ
Head Neck; 2017 Jan; 39(1):133-139. PubMed ID: 27534388
[TBL] [Abstract][Full Text] [Related]
6. Treatment and Prognosis of Anaplastic Thyroid Carcinoma: A Clinical Study of 50 Cases.
Liu TR; Xiao ZW; Xu HN; Long Z; Wei FQ; Zhuang SM; Sun XM; Xie LE; Mu JS; Yang AK; Zhang GP; Fan Y
PLoS One; 2016; 11(10):e0164840. PubMed ID: 27760217
[TBL] [Abstract][Full Text] [Related]
7. Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany.
Wendler J; Kroiss M; Gast K; Kreissl MC; Allelein S; Lichtenauer U; Blaser R; Spitzweg C; Fassnacht M; Schott M; Führer D; Tiedje V
Eur J Endocrinol; 2016 Dec; 175(6):521-529. PubMed ID: 27926471
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.
Rao SN; Zafereo M; Dadu R; Busaidy NL; Hess K; Cote GJ; Williams MD; William WN; Sandulache V; Gross N; Gunn GB; Lu C; Ferrarotto R; Lai SY; Cabanillas ME
Thyroid; 2017 May; 27(5):672-681. PubMed ID: 28068873
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
Fan D; Ma J; Bell AC; Groen AH; Olsen KS; Lok BH; Leeman JE; Anderson E; Riaz N; McBride S; Ganly I; Shaha AR; Sherman EJ; Tsai CJ; Kang JJ; Lee NY
Cancer; 2020 Jan; 126(2):444-452. PubMed ID: 31593317
[TBL] [Abstract][Full Text] [Related]
10. Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer: A Single-Institution 21-Year Experience.
Wu SS; Lamarre ED; Yalamanchali A; Brauer PR; Hong H; Reddy CA; Yilmaz E; Woody N; Ku JA; Prendes B; Burkey B; Nasr C; Skugor M; Heiden K; Chute DJ; Knauf JA; Campbell SR; Koyfman SA; Geiger JL; Scharpf J
JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):300-309. PubMed ID: 36757708
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic thyroid carcinoma: a 25-year single-institution experience.
Mohebati A; Dilorenzo M; Palmer F; Patel SG; Pfister D; Lee N; Tuttle RM; Shaha AR; Shah JP; Ganly I
Ann Surg Oncol; 2014 May; 21(5):1665-70. PubMed ID: 24554064
[TBL] [Abstract][Full Text] [Related]
12. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic thyroid carcinoma: Failure of conventional therapy but hope of targeted therapy.
Lennon P; Deady S; Healy ML; Toner M; Kinsella J; Timon CI; O'Neill JP
Head Neck; 2016 Apr; 38 Suppl 1():E1122-9. PubMed ID: 26879282
[TBL] [Abstract][Full Text] [Related]
14. Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma.
Nachalon Y; Stern-Shavit S; Bachar G; Shvero J; Limon D; Popovtzer A
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1128-32. PubMed ID: 26512447
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.
Sugitani I; Miyauchi A; Sugino K; Okamoto T; Yoshida A; Suzuki S
World J Surg; 2012 Jun; 36(6):1247-54. PubMed ID: 22311136
[TBL] [Abstract][Full Text] [Related]
16. The role of surgery in the treatment of thyroid anaplastic carcinoma in the elderly.
Polistena A; Monacelli M; Lucchini R; Triola R; Conti C; Avenia S; Rondelli F; Bugiantella W; Barillaro I; Sanguinetti A; Avenia N
Int J Surg; 2014; 12 Suppl 2():S170-S176. PubMed ID: 25167852
[TBL] [Abstract][Full Text] [Related]
17. Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery.
Jacobsen AB; Grøholt KK; Lorntzsen B; Osnes TA; Falk RS; Sigstad E
Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4203-4209. PubMed ID: 29019001
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and prognosis of anaplastic thyroid carcinoma: a 20-year single-center retrospective study].
Wei YC; Zhang D; Chai Y; Dong M
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Mar; 58(3):218-224. PubMed ID: 36878500
[No Abstract] [Full Text] [Related]
19. Anaplastic thyroid cancer: a case report of a long term survival patient and review of literature data.
Ursino S; Fiorica F; Stefanelli A; Pedriali M; Colosimo C; Cocuzza P; Mazzotti V; Taibi R; Cartei F; Greco C
Eur Rev Med Pharmacol Sci; 2014; 18(9):1368-72. PubMed ID: 24867515
[TBL] [Abstract][Full Text] [Related]
20. Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: Propensity score matched analysis with multiple subgroups.
Tian S; Switchenko JM; Fei T; Press RH; Abugideiri M; Saba NF; Owonikoko TK; Chen AY; Beitler JJ; Curran WJ; Gillespie TW; Higgins KA
Head Neck; 2020 Apr; 42(4):678-687. PubMed ID: 31845469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
